Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect

• DOI: 10.1007/s10517-021-05230-3
• Publication Date: 2021-07-22T06:02:51Z
• Authors: A. M. Burdennyy; E. A. Filippova; N. A. Ivanova; S. S. Lukina; I. V. Pronina; V. I. Loginov; M. V. Fridman; T. P. Kazubskaya; D. O. Utkin; E. A. Braga; N. E. Kushlinskii
• Keywords: Ovarian Neoplasms; 0303 health sciences; Epithelial-Mesenchymal Transition; Membrane Glycoproteins; Semaphorins; DNA Methylation; Cystadenocarcinoma, Serous; 3. Good health; Gene Expression Regulation, Neoplastic; 03 medical and health sciences; Humans; Female; RNA, Long Noncoding; Neoplasm Grading; Carcinoma, Endometrioid; Peritoneal Neoplasms; Neoplasm Staging

The role of methylation in the regulation of genes of long noncoding RNA (lncRNA) is still poorly understood. We revealed new hypermethylated lncRNA genes in ovarian tumors and their effect on metastasis of ovarian cancer. A multiple and significant (p<0.001) increase in methylation of a group of lncRNA genes (MEG3, SEMA3B-AS1, ZNF667-AS1, and TINCR) was shown by quantitative methylation-specific PCR using the non-parametric Mann-Whitney test. Moreover, methylation of SEMA3B-AS1, ZNF667-AS1, and TINCR genes in ovarian cancer tumors was detected for the first time. Comparative analysis of 19 samples of peritoneal metastases and paired primary tumors showed a significant decrease in the methylation level of the same 4 genes: MEG3 (p=0.004), SEMA3B-AS1 (p=0.002), TINCR (p=0.002), and ZNF667-AS1 (p<0.001). Reduced methylation of suppressor lncRNA genes in peritoneal metastases is probably associated with the involvement of these lncRNA in the regulation of plastic reversion of the epithelial-mesenchymal transition to the mesenchymal-epithelial transition. Thus, the effect of lncRNA and their methylation on the development of tumors and metastases of ovarian cancer was demonstrated, which is important for understanding of the pathogenesis and mechanisms of metastasis of ovarian cancer. New properties of lncRNA can find application in the development of new approaches in the therapy of ovarian cancer.